New tumor suppressor gene identified
A recent study published in Clinical Cancer Research suggests that the protein hVps37A suppresses tumor growth in ovarian cancer. The work, which was funded by the Austrian Science Fund FWF, shows, for th ...
Cancer
Feb 13, 2012 |
4.8 / 5 (4) |
0
Short fasting cycles work as well as chemotherapy in mice
Man may not live by bread alone, but cancer in animals appears less resilient, judging by a study that found chemotherapy drugs work better when combined with cycles of short, severe fasting.
Cancer
Feb 08, 2012 |
4.7 / 5 (17) |
3
|
'DIMming' cancer growth -- STAT: Diindolylmethane suppresses ovarian cancer
Ovarian cancer is a major cause of death worldwide. Approximately 25,000 women will be diagnosed with ovarian cancer this year and 15,000 women will die from it in the United States alone. The novel anti-cancer drug diindolylmethane ...
Cancer
Jan 26, 2012 |
not rated yet |
1
UH Case Medical Center offers new therapy for gynecologic cancer patients
Patients with gynecologic cancer have new hope in a novel technology now offered at the Seidman Cancer Center at University Hospitals (UH) Case Medical Center. A team of cancer specialists, led by Robert DeBernardo, MD, is ...
Cancer
Jan 20, 2012 |
not rated yet |
0
Breakthrough in early cancer detection
Cape Cod-TV correspondent Melissa Chartrand went into the hospital three years ago to undergo a hysterectomy, a common procedure that was supposed to eliminate her abdominal pains. But for Melissa, a far more serious pain ...
Cancer
Jan 10, 2012 |
not rated yet |
1
Researchers shorten time for manufacturing of personalized ovarian cancer vaccine
(Medical Xpress) -- Researchers from the Perelman School of Medicine at the University of Pennsylvania are in the midst of testing a personalized, dendritic cell vaccine in patients with recurrent ovarian, primary peritoneal ...
Cancer
Dec 26, 2011 |
3.5 / 5 (2) |
0
|
Study shows potential of anti-growth factor drugs for reducing complication of advanced ovarian cancer
Blocking the action of vascular endothelial growth factor (VEGF) with the new anti-VEGF drug aflibercept can curb the development of malignant ascites (excessive fluid in the abdomen), a common and painful complication of ...
Cancer
Dec 20, 2011 |
not rated yet |
0
Breast cancer and heart disease may have common roots
Women who are at risk for breast cancer may also be at greater risk for heart disease, new research has found.
Genetics
Dec 20, 2011 |
not rated yet |
0
|
Evolving ovarian cancer cells 'dodge' treatment with chemotherapy
(Medical Xpress) -- Cancer Research UK scientists have discovered that the commonest type of ovarian cancer evolves at a startling rate, which may allow cancer cells to ‘dodge’ the current standard treatment, reveals ...
Cancer
Dec 20, 2011 |
not rated yet |
0
Cancer from fetal exposure to carcinogens depends on dose, timing
The cancer-causing potential of fetal exposure to carcinogens can vary substantially, a recent study suggests, causing different types of problems much later in life depending on the stage of pregnancy when the fetus is exposed.
Cancer
Dec 15, 2011 |
not rated yet |
0
|
Researchers find drug duo kills chemotherapy-resistant ovarian cancer cells
The use of two drugs never tried in combination before in ovarian cancer resulted in a 70 percent destruction of cancer cells already resistant to commonly used chemotherapy agents, say researchers at Mayo Clinic in Florida. ...
Cancer
Dec 07, 2011 |
not rated yet |
0
New study identifies novel role for PEA-15 protein in cancer growth
A new study from the University of Hawaii Cancer Center reveals that PEA-15, a protein previously shown to slow ovarian tumor growth and metastasis, can alternatively enhance tumor formation in kidney cells carrying a mutation ...
Cancer
Nov 21, 2011 |
5 / 5 (1) |
0
|
New model establishes guidelines for earlier cancer detection
Tumors can grow for 10 years or longer before currently available blood tests will detect them, a new mathematical model developed by Stanford University School of Medicine scientists indicates. The analysis, which was restricted ...
Cancer
Nov 16, 2011 |
not rated yet |
0
|
Predicting cellular response to paclitaxel in epithelial ovarian cancer
(Medical Xpress) -- New research findings by UCD scientists published online in the Journal of Pathology may help clinicians predict how patients with high grade, serous, epithelial ovarian cancer will r ...
Cancer
Nov 16, 2011 |
not rated yet |
0
Discovery may help fight late-stage ovarian cancer
A potential breakthrough in treating late-stage ovarian cancer has come from University of Guelph researchers who have discovered a peptide that shrinks advanced tumours and improves survival rates for this deadly but often ...
Cancer
Nov 16, 2011 |
not rated yet |
0
